Literature DB >> 294830

The effect of THF in lymphoproliferative and myeloproliferative diseases in children.

R Zaizov, R Vogel, B Wolach, I J Cohen, I Varsano, B Shohat, Z Handzel, V Rotter, Y Yakir, N Trainin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 294830     DOI： 10.1111/j.1749-6632.1979.tb47110.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  A controlled trial of treatment of acquired immunodeficiency in severe measles with thymic humoral factor.

Authors:  D W Beatty; Z T Handzel; M Pecht; C R Ryder; J Hughes; K McCabe; N Trainin
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

2.  THF-gamma 2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma.

Authors:  R Ophir; M Pecht; D Halperin; G Rashid; Y Burstein; S Ben-Efraim; N Trainin
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice.

Authors:  C Goso; D Frasca; G Doria
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

4.  Effect of a thymic factor, thymostimulin, on growth and pulmonary metastases of Lewis lung carcinoma.

Authors:  M Yagi; T Yamashita; E Tsubura
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.